PCVX Earnings & Financial Statements - Vaxcyte, Inc. logo

PCVX Earnings & Financial Statements

Vaxcyte, Inc.

$59.22
+$0.70(+1.20%)
41
Overall
60
Value
33
Tech
31
Quality
How is this score calculated?
Market Cap
$9.37B
Volume
385.54K
52W Range
$42.40 - $90.75
Target Price
$116.50

PCVX earnings and financial statements: Vaxcyte, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.

PCVX Annual Financial Statements

PCVX income statement
Fiscal year20252024202320222021
Operating income-$923.67M-$569.55M-$468.04M-$232.26M-$103.67M
EBITDA-$898.82M-$448.08M-$392.10M-$214.29M-$96.61M
Net income-$766.63M-$463.93M-$402.27M-$223.49M-$100.08M
EPS (diluted)$-5.63$-3.80$-4.14$-3.44$-1.93
PCVX balance sheet
Fiscal year20252024202320222021
Total assets$3.00B$3.51B$1.41B$1.01B$324.34M
Total liabilities$317.21M$205.50M$167.45M$52.56M$40.32M
Shareholders’ equity$2.69B$3.31B$1.24B$953.61M$284.02M
Cash and equivalents$173.96M$387.88M$397.45M$834.66M$68.98M
Long-term debt$111.36M$65.22M$22.11M$12.03M$11.51M
PCVX cash flow statement
Fiscal year20252024202320222021
Operating cash flow-$655.58M-$452.63M-$296.79M-$170.60M-$121.39M
Capital expenditure-$56.97M-$22.43M-$67.88M-$5.84M-$6.55M
Free cash flow-$712.55M-$475.05M-$312.85M-$176.44M-$127.95M
ABCD
1SymbolPriceChangeVol
2PCVX$59.22+1.2%385.54K
3
4
5
6

Get Vaxcyte, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.